Table 4.
Patients | Patients | ||||
---|---|---|---|---|---|
Follow-up | Patients | Improved | Failed | ||
Study | Patients | (mo) | Dry (%) | (%) | (%) |
Cervigni and Panei7 | 14 | 9.7 | 8 (57) | 4 (29) | 2 (14) |
Santarosa and | 12 | 11 | 7 (58) | 5 (42) | |
Blaivas82 | |||||
Trockman and | 32 | 6 | 4 (12) | 14 (44) | 14 (44) |
Leach57 | |||||
Haab et al60 | 45 | 7 | 6 (13) | 13 (29) | 26 (58) |
Su et al58 | 26 | Mean: 17.4 | 13 (50) | 4 (15) | 9 (35) |
(range, | |||||
12–30) | |||||
Palma et al59 | 30 | 12 | 1 injection: | ||
4/13 (31) | |||||
2 injections: | |||||
11/17 (64) |